Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Over the Counter (OTC) Drugs & Dietary Supplements Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Vitamin and Dietary Supplements
      • 1.3.3 Cough & Cold Products
      • 1.3.4 Analgesics
      • 1.3.5 Gastrointestinal Products
      • 1.3.6 Sleep Aids
      • 1.3.7 Otic Products
      • 1.3.8 Wart Removers
      • 1.3.9 Mouth Care Products
      • 1.3.10 Ophthalmic Products
      • 1.3.11 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2025)
      • 1.4.2 Pharmacies
      • 1.4.3 Grocery Stores
      • 1.4.4 Vitamin
      • 1.4.5 Health Food Stores
      • 1.4.6 Online Pharmacies
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size
      • 2.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue 2014-2025
      • 2.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2014-2025
    • 2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Rate by Regions
      • 2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Regions 2014-2019
      • 2.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers
      • 3.1.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers 2014-2019
      • 3.1.2 Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2014-2019)
      • 3.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)
    • 3.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Manufacturers
    • 3.4 Key Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
    • 3.6 Key Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Vitamin and Dietary Supplements Sales and Revenue (2014-2019)
      • 4.1.2 Cough & Cold Products Sales and Revenue (2014-2019)
      • 4.1.3 Analgesics Sales and Revenue (2014-2019)
      • 4.1.4 Gastrointestinal Products Sales and Revenue (2014-2019)
      • 4.1.5 Sleep Aids Sales and Revenue (2014-2019)
      • 4.1.6 Otic Products Sales and Revenue (2014-2019)
      • 4.1.7 Wart Removers Sales and Revenue (2014-2019)
      • 4.1.8 Mouth Care Products Sales and Revenue (2014-2019)
      • 4.1.9 Ophthalmic Products Sales and Revenue (2014-2019)
      • 4.1.10 Other Sales and Revenue (2014-2019)
    • 4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type
    • 4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type
    • 4.4 Over the Counter (OTC) Drugs & Dietary Supplements Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application

    6 United States

    • 6.1 United States Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Company
    • 6.2 United States Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
    • 6.3 United States Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application

    7 European Union

    • 7.1 European Union Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Company
    • 7.2 European Union Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
    • 7.3 European Union Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application

    8 China

    • 8.1 China Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Company
    • 8.2 China Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
    • 8.3 China Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Company
    • 9.2 Rest of World Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
    • 9.3 Rest of World Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application
    • 9.4 Rest of World Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Countries
      • 9.4.1 Rest of World Over the Counter (OTC) Drugs & Dietary Supplements Sales by Countries
      • 9.4.2 Rest of World Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer Inc.
      • 10.1.1 Pfizer Inc. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.1.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.1.5 Pfizer Inc. Recent Development
    • 10.2 Novartis International AG
      • 10.2.1 Novartis International AG Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.2.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.2.5 Novartis International AG Recent Development
    • 10.3 Roche Holding AG
      • 10.3.1 Roche Holding AG Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.3.5 Roche Holding AG Recent Development
    • 10.4 Merck & Co., Inc.
      • 10.4.1 Merck & Co., Inc. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.4.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.4.5 Merck & Co., Inc. Recent Development
    • 10.5 Sanofi S.A
      • 10.5.1 Sanofi S.A Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.5.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.5.5 Sanofi S.A Recent Development
    • 10.6 Johnson & Johnson
      • 10.6.1 Johnson & Johnson Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.6.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.6.5 Johnson & Johnson Recent Development
    • 10.7 Gilead Sciences
      • 10.7.1 Gilead Sciences Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.7.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.7.5 Gilead Sciences Recent Development
    • 10.8 GlaxoSmithKline plc.
      • 10.8.1 GlaxoSmithKline plc. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.8.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.8.5 GlaxoSmithKline plc. Recent Development
    • 10.9 Bayer Healthcare AG
      • 10.9.1 Bayer Healthcare AG Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.9.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.9.5 Bayer Healthcare AG Recent Development
    • 10.10 AstraZeneca plc.
      • 10.10.1 AstraZeneca plc. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Over the Counter (OTC) Drugs & Dietary Supplements
      • 10.10.4 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
      • 10.10.5 AstraZeneca plc. Recent Development
    • 10.11 Alacer Corp.
    • 10.12 Alcon Inc.
    • 10.13 Alfresa Pharma Corporation
    • 10.14 Alkalon A/S
    • 10.15 Alliance Healthcare
    • 10.16 Allergan, Plc.
    • 10.17 Reckitt Benckiser Plc.
    • 10.18 Bausch & Lomb
    • 10.19 AbbVie Inc.
    • 10.20 The Colgate-Palmolive Company

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales Channels
      • 11.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Distributors
    • 11.3 Over the Counter (OTC) Drugs & Dietary Supplements Customers

    12 Market Forecast

    • 12.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales and Revenue Forecast 2019-2025
    • 12.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type
    • 12.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application
    • 12.4 Over the Counter (OTC) Drugs & Dietary Supplements Forecast by Regions
      • 12.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.
      In 2019, the market size of Over the Counter (OTC) Drugs & Dietary Supplements is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Over the Counter (OTC) Drugs & Dietary Supplements.

      This report studies the global market size of Over the Counter (OTC) Drugs & Dietary Supplements, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Over the Counter (OTC) Drugs & Dietary Supplements sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer Inc.
      Novartis International AG
      Roche Holding AG
      Merck & Co., Inc.
      Sanofi S.A
      Johnson & Johnson
      Gilead Sciences
      GlaxoSmithKline plc.
      Bayer Healthcare AG
      AstraZeneca plc.
      Alacer Corp.
      Alcon Inc.
      Alfresa Pharma Corporation
      Alkalon A/S
      Alliance Healthcare
      Allergan, Plc.
      Reckitt Benckiser Plc.
      Bausch & Lomb
      AbbVie Inc.
      The Colgate-Palmolive Company

      Market Segment by Product Type
      Vitamin and Dietary Supplements
      Cough & Cold Products
      Analgesics
      Gastrointestinal Products
      Sleep Aids
      Otic Products
      Wart Removers
      Mouth Care Products
      Ophthalmic Products
      Other

      Market Segment by Application
      Pharmacies
      Grocery Stores
      Vitamin
      Health Food Stores
      Online Pharmacies

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Over the Counter (OTC) Drugs & Dietary Supplements status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Over the Counter (OTC) Drugs & Dietary Supplements manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Over the Counter (OTC) Drugs & Dietary Supplements are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now